Trial of the CarePartner Program for Improving the Quality of Transition Support
Background: Patients hospitalized with complex chronic conditions frequently experience preventable short-term readmissions due to inadequate transition support. Although structured discharge planning with telephone follow-up improves transition outcomes, these services often are unavailable, and proactive outreach is often inadequate once the patient returns home. Informal caregivers are invaluable for ensuring successful transitions, but many patients live alone, have an in-home caregiver who is struggling with competing demands, or live at a distance from adult children or other potential sources of support. New models are needed for transition support that include low-cost technologies and more structured assistance for patients' informal caregiving network, while providing patients' clinical teams with the information they need to avert health crises.
Objectives: Consistent with Agency for Healthcare Research and Quality goals to improve transitions using accessible health IT, we will evaluate a novel intervention designed to improve the effectiveness of transition support for common chronic conditions via three mechanisms of action: (a) direct tailored communication to patients via automated calls post discharge, (b) support for informal caregivers via structured feedback about the patient's status and advice about how they can help, and (c) support for proactive care management including a web-based disease management tool, automated alerts about potential problems, and the capacity for asynchronous communication with patients and their caregivers. Specifically, the trial will determine: 1) whether the CarePartner intervention improves patients' readmission risk and functional status; 2) the impact of the intervention on patients' self-care behaviors and the quality of the transition process; and 3) whether the intervention improves caregiver burden and stress levels.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
|Official Title:||Trial of the CarePartner Program for Improving the Quality of Transition Support|
- Specific Aim 1 [ Time Frame: Outcomes will be measured at 30- and 90-days post discharge. ] [ Designated as safety issue: No ]To determine the extent to which the CarePartner model for supporting effective transitions from hospital to home improves outcomes of care, including short-term readmission rates, emergency department visits, and patients' functional status.
- Specific Aim 2 [ Time Frame: Outcomes will be measured at 30- and 90-days post discharge. ] [ Designated as safety issue: No ]To evaluate the impact of the CarePartner intervention on process measures of transition quality and on patients' medication-related self-management.
- Specific Aim 3 [ Time Frame: Outcomes will be measured at 30- and 90-days post discharge. ] [ Designated as safety issue: No ]To determine the extent to which the intervention increases the quality and quantity of support for patients' self-care using a mixed methods approach to identify whether the service reduces stress and increases activation levels among CarePartners.
|Study Start Date:||August 2012|
|Estimated Primary Completion Date:||June 2015 (Final data collection date for primary outcome measure)|
Experimental: Intervention Group
Telemonitoring plus self-management support
Other: Telemonitoring plus self-management support
Patients in the intervention group receive automated telephone calls that ask about their health and self-care along with tailored health-related feedback. The patient's CarePartner receives health update reports about the patient and how they can help via e-mail. Urgent health problems are reported to the patient's health care team via fax or e-mail.
No Intervention: Usual Care Group
Please refer to this study by its ClinicalTrials.gov identifier: NCT01672398
|United States, Michigan|
|University of Michigan Health System|
|Ann Arbor, Michigan, United States, 48109|
|Principal Investigator:||John D. Piette, Ph.D.||VA Center for Clinical Management Research & the University of Michigan|